The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

Breast

Prostate & urology

Lung & pleura

Colorectal & gastro

Melanoma & skin

Head & neck

Ovary & gynaecology

+ -

Increasing prostate cancer awareness

ECCO 15 - ESMO 34

20 - 24 Sep 2009

Published: 3 Nov 2009

Views: 12071

Rating:

Save

Tom Hudson - Chair of Europa Uomo

Tom Hudson discusses Europa Uomo's aim to increase awareness of prostate cancer and the importance of presenting symptoms.

Related Videos

OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for November 29th - December 5th, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Comparison of health access, lifestyle, prostate cancer knowledge, and screening...

Dr Orlando Rivera Colón - University of Central Florida, Florida, USA

Comparison of health access, lifestyle, prostate cancer knowledge, and screening among black men residing in West Africa and the USA ( Dr Orlando Rivera Colón - University of Central Florida, Florida, USA )

Cancer Health Disparities Special Issue - Editorial

Prof Folakemi Odedina - University of Florida, Tampa, USA

Cancer Health Disparities Special Issue - Editorial ( Prof Folakemi Odedina - University of Florida, Tampa, USA )

PARP inhibitors in prostate cancer: Case based testing and clinical decisions

Dr Neal Shore and Prof Fred Saad

PARP inhibitors in prostate cancer: Case based testing and clinical decisions ( Dr Neal Shore and Prof Fred Saad )

Current state of prostate cancer in Antigua and Barbuda

Dr Adrian Rhudd - Mount St. John’s Medical Centre, Antigua, Antigua and Barbuda

Current state of prostate cancer in Antigua and Barbuda ( Dr Adrian Rhudd - Mount St. John’s Medical Centre, Antigua, Antigua and Barbuda )

Part 1: When to test

PARP inhibition in the treatment of prostate cancer

Part 1: When to test ( PARP inhibition in the treatment of prostate cancer )

Part 2: Who to test

PARP inhibition in the treatment of prostate cancer

Part 2: Who to test ( PARP inhibition in the treatment of prostate cancer )

The role of testing in prostate cancer treatment

Prof Phil Cornford, Dr Joaquin Mateo, Prof Alex Wyatt and Prof Derya Tilki

The role of testing in prostate cancer treatment ( Prof Phil Cornford, Dr Joaquin Mateo, Prof Alex Wyatt and Prof Derya Tilki )

Prostate cancer screening using prostate-specific antigen, a multiplex blood-tes...

Prof Martin Eklund - Karolinska Institutet, Solna, Sweden

Prostate cancer screening using prostate-specific antigen, a multiplex blood-test, MRI and targeted prostate biopsies ( Prof Martin Eklund - Karolinska Institutet, Solna, Sweden )

More from ecancer